Welcome to LookChem.com Sign In|Join Free

CAS

  • or

66131-78-0

Post Buying Request

66131-78-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

66131-78-0 Usage

General Description

2-ACETYLAMINO-5-IODOPYRIDINE is a chemical compound with the molecular formula C8H8IN3O. It is a pyridine derivative with an acetylamine group and an iodine atom attached to the 5th position of the pyridine ring. 2-ACETYLAMINO-5-IODOPYRIDINE is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has been studied for its potential as a building block in the synthesis of various biologically active compounds. 2-ACETYLAMINO-5-IODOPYRIDINE is known for its diverse applications in the pharmaceutical and agricultural industries, and its synthesis and properties are the subject of ongoing research.

Check Digit Verification of cas no

The CAS Registry Mumber 66131-78-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,1,3 and 1 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 66131-78:
(7*6)+(6*6)+(5*1)+(4*3)+(3*1)+(2*7)+(1*8)=120
120 % 10 = 0
So 66131-78-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H7IN2O/c1-5(11)10-7-3-2-6(8)4-9-7/h2-4H,1H3,(H,9,10,11)

66131-78-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(5-iodopyridin-2-yl)acetamide

1.2 Other means of identification

Product number -
Other names N-(5-iodo-[2]pyridyl)-acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66131-78-0 SDS

66131-78-0Relevant articles and documents

COMPOUND HAVING ZNF143 INHIBITORY ACTIVITY AND USE THEREOF

-

Paragraph 0078, (2016/10/27)

PROBLEM TO BE SOLVED: To provide a compound having a ZNF143 inhibitory activity as well as to provide a ZNF143 inhibitory agent and pharmaceutical composition containing the same. SOLUTION: Provided is a compound represented by formula (I) or a salt thereof as well as a ZNF143 inhibitory agent containing the same and a pharmaceutical composition having the same as an active ingredient. A-B-C-D (I)[A is H, a methyl group, a naphthyl group, a phenyl group or a nitrogen-containing heterocyclic ring; B is as shown below, and C is an amide bond or a heteroaromatic ring containing N and O; D is a substituted/unsubstituted phenyl group or a monocyclic heteroaromatic ring containing N or S; and C and D are both fused heterocyclic ring or the like optionally having a substituent group.]. SELECTED DRAWING: Figure 1 COPYRIGHT: (C)2016,JPOandINPIT

SUBSTITUTED PYRIDINE DERIVATIVES AS FABI INHIBITORS

-

Page/Page column 76, (2013/06/27)

The present invention provides substituted pyridine derivatives of formula (I), which may be therapeutically useful as as anti-bacterial agents, more particulalrly FabI inhibitors. Formula(I) in which R1 to R5 and L have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage anti-bacterial agents, more particularly FabI inhibitors. The present invention also provides methods for synthesizing and administering the FabI inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the FabI inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

Synthesis and structure elucidation of new cytotoxic azathioxanthones

Varvaresou,Tsotinis,Papadaki-Valiraki,Siatra-Papastaikoudi

, p. 917 - 921 (2007/10/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 66131-78-0